Company News 

Smiths hit by EU regulation

Smiths hit by EU regulation

You couldn’t accuse Smiths Group (SMIN) of downplaying the performance issues at its healthcare arm, but the FTSE 100 conglomerate hadn’t really provided any numbers to flesh out the concerns – until now.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now